Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 10:12:1533950.
doi: 10.3389/fmed.2025.1533950. eCollection 2025.

Impact of preoperative intraocular pressure on corneal endothelial cell loss after phacoemulsification in acute primary angle-closure glaucoma with cataracts

Affiliations

Impact of preoperative intraocular pressure on corneal endothelial cell loss after phacoemulsification in acute primary angle-closure glaucoma with cataracts

Jiaqi Shen et al. Front Med (Lausanne). .

Abstract

Purpose: This study aimed to assess corneal endothelial cell loss (ECL) following phacoemulsification and intraocular lens implantation (Phaco+IOL) in eyes with acute primary angle-closure glaucoma (APACG) and cataracts under different preoperative intraocular pressure (IOP) levels.

Methods: This non-randomized controlled trial included 75 eyes from 75 patients with APACG and cataracts who underwent Phaco+IOL. All patients received pharmacotherapy and anterior chamber paracentesis before surgery and were grouped according to their preoperative IOP: the high-IOP group (IOP ≥ 25 mmHg) and the IOP-controlled group (IOP < 25 mmHg). IOP, visual outcome, endothelial cell density (ECD), hexagonality (HEX), coefficient of variation (CV), and central corneal thickness (CCT) were evaluated up to 3 months postoperatively. Baseline ECD, HEX, and CV parameters were measured in the contralateral eyes of all patients as a reference and compared with the postoperative results.

Results: The average IOP decreased from 43.2 ± 4.8 mmHg to 16.5 ± 5.8 mmHg (p < 0.001) in the high-IOP group and from 18.3 ± 4.3 mmHg to 14.3 ± 3.2 mmHg (p < 0.001) in the IOP-controlled group on the first postoperative day. The changes in IOP were more significant in the high-IOP group (p < 0.001). The ECD at 3 months was 1705.2 ± 503.8 cells/mm2 in the high-IOP group and 2091.8 ± 330.1 cells/mm2 in the IOP-controlled group (p < 0.001). The ECL rates at 3 months were 35.0% (high-IOP group) and 17.4% (IOP-controlled group) (p < 0.001). The postoperative changes in HEX and CV at 3 months were more significant in the high-IOP group (p < 0.001; p = 0.003). Both groups produced comparable improvements in visual acuity and IOP.

Conclusion: Uncontrolled high IOP (≥ 25 mmHg) before Phaco+IOL in patients with APACG and cataracts is associated with a higher rate of ECL. The rapid and substantial reduction of IOP during surgery may exacerbate corneal endothelial cell loss.

Clinical trial registration: ClinicalTrails.gov, identifier ChiCTR2100052096.

Keywords: acute primary angle-closure glaucoma; corneal endothelial cell loss; endothelial cell density; ocular hypertension; phacoemulsification.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(a) Change trend of IOP in the high-IOP group and the IOP-controlled group before and after surgery. (b) Change trend of ECD in the high-IOP group and IOP-controlled group before and after surgery. Error bars represent standard deviation. (c) The cornea of the patient in the IOP-controlled group after surgery: (ci,di) Corneal state under slit-lamporneal endothelium. (cii,dii) CECs were determined by a non-contact specular microscope and a computer-aid image analysis system.

References

    1. Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. Lancet. (2017) 390:2183–93. doi: 10.1016/S0140-6736(17)31469-1, PMID: - DOI - PubMed
    1. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. (2014) 121:2081–90. doi: 10.1016/j.ophtha.2014.05.013, PMID: - DOI - PubMed
    1. Reis TF, Paula JS, Furtado JM. Primary glaucomas in adults: epidemiology and public health-a review. Clin Experiment Ophthalmol. (2022) 50:128–42. doi: 10.1111/ceo.14040, PMID: - DOI - PubMed
    1. Azuara-Blanco A, Burr J, Ramsay C, Cooper D, Foster PJ, Friedman DS, et al. . Effectiveness of early lens extraction for the treatment of primary angleclosure glaucoma (EAGLE): a randomised controlled trial. Lancet. (2016) 388:1389–97. doi: 10.1016/S0140-6736(16)30956-4, PMID: - DOI - PubMed
    1. Husain R, Do T, Lai J, Kitnarong N, Nongpiur ME, Perera SA, et al. . Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmol. (2019) 137:1107–13. doi: 10.1001/jamaophthalmol.2019.2493, PMID: - DOI - PMC - PubMed

LinkOut - more resources